Quarterly ResultApr 26, 2026, 05:30 AM
AGMB Reports Full Year 2025 Results; Confirms 2026 Outlook
AI Summary
Agomab Therapeutics NV announced its full year 2025 financial results and confirmed its 2026 outlook via a press release on April 23, 2026. Concurrently, the company published materials related to its Annual General Meeting (AGM), which is scheduled for May 26, 2026. These materials, including the Convening Notice and Annual Report, were made available on its website and furnished as exhibits.
Key Highlights
- Agomab Therapeutics NV reported its full year 2025 financial results.
- The company confirmed its 2026 outlook.
- Materials for the Annual General Meeting (AGM) were published on the company's website.
- The AGM is scheduled to be held on May 26, 2026, at 4:00 pm CEST.
- Exhibits include the press release, Convening Notice, Proxy Form, Voting Instructions, and Annual Report for the AGM.
Price Impact
More from AGMB